HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 31.25
Day range
zł 30.70 - zł 31.70
Year range
zł 17.62 - zł 55.20
Market cap
732.91M PLN
Avg Volume
47.94K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 21.03M | -17.27% |
Operating expense | 45.08M | 4.76% |
Net income | -25.28M | -30.30% |
Net profit margin | -120.17 | -57.50% |
Earnings per share | — | — |
EBITDA | -25.34M | -28.64% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.09M | -25.86% |
Total assets | 318.50M | -21.32% |
Total liabilities | 198.90M | -5.07% |
Total equity | 119.60M | — |
Shares outstanding | 23.12M | — |
Price to book | 6.04 | — |
Return on assets | -19.90% | — |
Return on capital | -29.52% | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.28M | -30.30% |
Cash from operations | -44.18M | -2.19% |
Cash from investing | 37.16M | -51.72% |
Cash from financing | -1.32M | -103.89% |
Net change in cash | -8.31M | -111.58% |
Free cash flow | -35.10M | -58.35% |
About
Founded
2007
Website
Employees
328
